TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · IEX Real-Time Price · USD
0.296
-0.006 (-2.02%)
At close: Jul 26, 2024, 4:00 PM
0.342
+0.046 (15.70%)
After-hours: Jul 26, 2024, 7:59 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $2.15 million as of July 26, 2024. Its market cap has decreased by -10.51% in one year.
Market Cap
2.15M
Enterprise Value
-2.39M
1-Year Change
-10.51%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $2.15M, a decrease of -95.51%. That is a compound annual growth rate of -63.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.00M | -39.39% |
| Dec 29, 2023 | 3.30M | -62.07% |
| Dec 30, 2022 | 8.70M | -73.48% |
| Dec 31, 2021 | 32.80M | -31.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 180 Life Sciences | 2.15M |
| Nuwellis | 2.14M |
| Windtree Therapeutics | 2.13M |
| NanoVibronix | 2.09M |
| Catheter Precision | 2.03M |
| Phio Pharmaceuticals | 1.92M |
| Tivic Health Systems | 1.90M |
| Galmed Pharmaceuticals | 1.89M |